Enthea

Enthea is a third-party administrator (TPA) that enables employers to offer innovative mental health benefits, including access to ketamine and, eventually, other FDA-approved psychedelic therapies. Their services are intended to address root causes of mental health challenges, rather than symptom management, with a focus on safety, credentialing, and compliance. Current offerings are limited to ketamine and its enantiomer esketamine, reflecting the only FDA-approved psychedelic therapies as of now. Enthea aims to collect real-world data to support broader adoption and to expand to other psychedelics pending FDA approvals[3][5].